Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00382_DB01165_nanopub.RAT_7toQeQX7sC7C-oUDT_D0PnnYBgg4veSAM2pl7_cpc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00382_DB01165 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00382_DB01165 label "DDI between Tacrine and Ofloxacin - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Ofloxacin. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Ofloxacin is initiated, discontinued or if the dose is changed. [drugbank_resource:DB00382_DB01165]" assertion.
- drugbank_resource:DB00382_DB01165 identifier "drugbank_resource:DB00382_DB01165" assertion.
- drugbank_resource:DB00382_DB01165 title "DDI between Tacrine and Ofloxacin - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Ofloxacin. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Ofloxacin is initiated, discontinued or if the dose is changed." assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB01165 assertion.
- drugbank:DB01165 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB01165 assertion.